{"id":656,"date":"2020-08-11T14:19:45","date_gmt":"2020-08-11T06:19:45","guid":{"rendered":"http:\/\/web.csh.org.tw\/web\/cshmagazine\/?p=656"},"modified":"2020-08-11T14:20:46","modified_gmt":"2020-08-11T06:20:46","slug":"%e9%a0%ad%e9%a0%b8%e7%99%8c%e6%b2%bb%e7%99%82%e7%9a%84%e9%80%b2%e5%b1%95","status":"publish","type":"post","link":"https:\/\/web.csh.org.tw\/web\/cshmagazine\/?p=656","title":{"rendered":"\u982d\u9838\u764c\u6cbb\u7642\u7684\u9032\u5c55"},"content":{"rendered":"\n

\u6587\/\u8840\u6db2\u816b\u7624\u79d1 \u5442\u5b78\u5112 <\/strong>\u4e3b\u4efb<\/p>\n\n\n\n

\"\"
\u8840\u6db2\u816b\u7624\u79d1\u00a0 \u5442\u5b78\u5112\u91ab\u5e2b<\/figcaption><\/figure><\/div>\n\n\n\n

\u6839\u64da2017\u5e74\u885b\u751f\u798f\u5229\u90e8\u7d71\u8a08\u8655\u516c\u544a\uff0c\u982d\u9838\u764c\u767c\u751f\u7387\u70ba\u53f0\u7063\u7b2c\u56db\u540d\uff0c\u4e14\u70ba\u53f0\u7063\u7b2c\u4e94\u5927\u764c\u75c7\u6b7b\u56e0\uff0c\u5305\u62ec\uff1a\u53e3\u8154\u764c\u3001\u53e3\u54bd\u764c\u3001\u4e0b\u54bd\u764c\u8207\u5589\u764c\u7b49\uff0c\u800c\u83f8\u3001\u9152\u3001\u6ab3\u6994\u7b49\u66f4\u662f\u982d\u9838\u764c\u7684\u9ad8\u5371\u96aa\u56e0\u5b50\uff0c\u5176\u7f79\u60a3\u982d\u9838\u764c\u4e4b\u6a5f\u7387\u9ad8\u9054300\u500d\u3002<\/p>\n\n\n\n

\u6548\u679c\u5353\u8d8a\uff01<\/strong>
\u4e2d\u5c71\u91ab\u982d\u9838\u764c\u5718\u968a \u6cbb\u7642\u6548\u679c\u582a\u6bd4\u570b\u969b\uff01<\/strong><\/p>\n\n\n\n

\u96a8\u8457\u85e5\u7269\u6cbb\u7642\u7684\u9032\u5c55\uff0c\u982d\u9838\u764c\u7684\u85e5\u7269\u6cbb\u7642\u8207\u6642\u4ff1\u9032\uff0c\u5305\u62ec\uff1a\u723e\u5fc5\u5f97\u8212(cetuximab)\u3001\u4fdd\u75be\u4f0f(Nivolumab)\u3001\u548c\u5409\u8212\u9054(keytruda)\uff0c\u5747\u662f\u9019\u5e7e\u5e74\u5728\u570b\u969b\u4e0a\u5c0d\u982d\u9838\u764c\u76f8\u7576\u77e5\u540d\u7684\u6cbb\u7642\u85e5\u7269\uff0c\u4e5f\u9678\u7e8c\u51fa\u73fe\u5728\u5065\u4fdd\u7d66\u4ed8\u85e5\u7269\u7684\u9078\u9805\u7576\u4e2d\u3002<\/p>\n\n\n\n

\u6839\u64da\u65b0\u82f1\u683c\u862d\u91ab\u5b78\u671f\u520a\u6307\u51fa\uff0c\u8f49\u79fb\u5fa9\u767c\u4e4b\u982d\u9838\u764c\u75c5\u60a3\uff0c\u63a5\u53d7\u904e\u723e\u5fc5\u5f97\u8212(cetuximab)\u6cbb\u7642\u5f8c\uff0c\u5176\u4e2d\u4f4d\u6578\u5b58\u6d3b\u671f\u5f9e\u539f\u672c\u76847.3\u500b\u6708\uff0c\u53ef\u4ee5\u63d0\u5347\u523010.1\u500b\u6708\uff0c\u800c\u6b64\u6a19\u9776\u85e5\u7269\u76ee\u524d\u4e5f\u6709\u5065\u4fdd\u7d66\u4ed8\u3002<\/p>\n\n\n\n

\u53e6\u5916\u6839\u64da\u672c\u9662\u764c\u75c7\u4e2d\u5fc3\u4e4b\u982d\u9838\u764c\u91ab\u7642\u5718\u968a\u7d71\u8a08\u986f\u793a\uff0c\u672c\u9662\u5fa9\u767c\u8f49\u79fb\u4e4b\u982d\u9838\u764c\u75c5\u60a3\uff0c\u63a5\u53d7\u723e\u5fc5\u5f97\u8212(cetuximab)\u5f8c\uff0c\u4e2d\u4f4d\u6578\u5b58\u6d3b\u671f\u751a\u81f3\u53ef\u4ee5\u9054\u523014.0\u500b\u6708\u3002\u7531\u6b64\u53ef\u898b\uff0c\u4e2d\u5c71\u9644\u91ab\u6709\u76f8\u7576\u5c08\u696d\u4e14\u6709\u7d93\u9a57\u7684\u982d\u9838\u764c\u591a\u5c08\u79d1\u5718\u968a\uff0c\u5b88\u8b77\u4f60\u6211\u7684\u5065\u5eb7\u3002<\/p>\n\n\n\n

\u672c\u5718\u968a\u4e5f\u9678\u7e8c\u65bc\u8fd1\u4e09\u5e74\uff0c\u5c07\u6b64\u81e8\u5e8a\u6210\u679c\u767c\u8868\u65bc\u7f8e\u570b\u764c\u75c7\u7814\u7a76\u5354\u6703\u5e74\u6703(American Associated Cancer Research, AACR)\u53ca\u7f8e\u570b\u81e8\u5e8a\u764c\u75c7\u91ab\u5b78\u6703\u5e74\u6703(American Society of Clinical Oncology, ASCO)\u7b49\u570b\u969b\u91cd\u8981\u4e14\u77e5\u540d\u7684\u764c\u75c7\u5e74\u6703\uff0c\u5747\u5f97\u5230\u4e16\u754c\u5404\u5730\u4e0d\u540c\u7684\u8ff4\u97ff\u8207\u6307\u6559\u3002<\/p>\n\n\n\n

\u53e6\u5916\uff0c\u514d\u75ab\u6cbb\u7642\u5c0d\u65bc\u982d\u9838\u764c\u75c7\u4e5f\u6709\u4e0d\u540c\u7684\u9069\u61c9\u75c7\uff0c\u53ef\u5c07\u539f\u672c\u8f49\u79fb\u5fa9\u767c\u7684\u982d\u9838\u764c\u4e8c\u7dda\u6cbb\u7642\uff0c\u63d0\u5347\u4e2d\u4f4d\u6578\u5b58\u6d3b\u671f\u81f37.7\u500b\u6708\uff0c\u672c\u9662\u76ee\u524d\u4ea6\u6709\u76f8\u95dc\u85e5\u7269\u4f7f\u7528\u53ca\u7d93\u9a57\u53ca\u6210\u679c\u767c\u8868\u3002<\/p>\n\n\n\n

\u672a\u4f86\u9019\u4e9b\u65b0\u4e00\u4ee3\u7684\u85e5\u7269\u6cbb\u7642\uff0c\u914d\u5408\u7cbe\u6e96\u91ab\u7642\u7684\u57fa\u56e0\u6aa2\u6e2c\uff0c\u5c0d\u65bc\u6cbb\u7642\u6210\u6548\u76f8\u5c0d\u8f03\u5dee\u7684\u982d\u9838\u764c\u800c\u8a00\uff0c\u5747\u662f\u4e0d\u53ef\u591a\u5f97\u7684\u5229\u5668\u3002<\/p>\n\n\n\n

\u65e9\u671f\u8a3a\u65b7\uff0c\u65e9\u671f\u6cbb\u7642\uff01<\/strong><\/p>\n\n\n\n

\u8fd1\u5e74\u4f86\uff0c\u885b\u751f\u798f\u5229\u90e8\u570b\u6c11\u5065\u5eb7\u7f72\u4e5f\u9678\u7e8c\u63a8\u52d5\u56db\u764c\u7be9\u6aa2\uff0c\u5176\u4e2d30\u6b72\u4ee5\u4e0a\u6709\u56bc\u904e\u6ab3\u6994\u6216\u5438\u83f8\u8005\u3001\u621618\u6b72\u4ee5\u4e0a\u6709\u56bc\u904e\u6ab3\u6994\u4e4b\u539f\u4f4f\u6c11\uff0c\u5f97\u6bcf\u5169\u5e74\u7be9\u6aa2\u53e3\u8154\u764c\u4e00\u6b21\uff0c\u5982\u6b64\u65e9\u671f\u8a3a\u65b7\u3001\u65e9\u671f\u6cbb\u7642\uff0c\u7d55\u5c0d\u662f\u6297\u764c\u7684\u4e0d\u4e8c\u6cd5\u9580\uff01<\/p>\n\n\n\n

\u6bcf\u4f4d\u75c5\u4eba\u7684\u75be\u75c5\u548c\u8eab\u9ad4\u72c0\u6cc1\u90fd\u4e0d\u76e1\u76f8\u540c\uff0c\u9700\u8981\u7684\u8a3a\u65b7\u65b9\u6cd5\u8207\u85e5\u7269\u6cbb\u7642\u9078\u64c7\u4e5f\u4e0d\u540c\uff0c\u5c24\u5176\u982d\u9838\u764c\u60a3\u8005\u6cbb\u7642\u66f4\u662f\u8907\u96dc\uff0c\u56e0\u6b64\u66f4\u9700\u8981\u591a\u5c08\u79d1\u5718\u968a\u63d0\u4f9b\u500b\u4eba\u5316\u7684\u6cbb\u7642\u65b9\u91dd\uff0c\u4f7f\u982d\u9838\u764c\u60a3\u8005\u7372\u5f97\u6700\u4f73\u7684\u6cbb\u7642\u3002\u56de\u6eaf\u7d71\u8a08\u4e2d\u5c71\u9644\u91ab\u904e\u53bb\u982d\u9838\u764c\u7684\u6cbb\u7642\u7d93\u9a57\uff0c\u53ca\u570b\u969b\u91ab\u5b78\u6703\u7684\u767c\u8868\uff0c\u5747\u53ef\u4ee5\u80af\u5b9a\u4e2d\u5c71\u9644\u91ab\u5c0d\u65bc\u982d\u9838\u764c\u6cbb\u7642\u7684\u6295\u5165\u53ca\u7528\u5fc3\u3002\u5718\u968a\u76ee\u524d\u4e5f\u7a4d\u6975\u5c0e\u5165\u7cbe\u6e96\u91ab\u7642\u7b49\u57fa\u56e0\u6aa2\u6e2c\u7684\u65b9\u6848\uff0c\u671f\u5f85\u6709\u4e00\u5929\u80fd\u9020\u798f\u3001\u5609\u60e0\u66f4\u5ee3\u5927\u7684\u75c5\u60a3\u5011\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"

\u6587\/\u8840\u6db2\u816b\u7624\u79d1 \u5442\u5b78\u5112 \u4e3b\u4efb \u6839\u64da2017\u5e74\u885b\u751f\u798f\u5229\u90e8\u7d71\u8a08\u8655\u516c\u544a\uff0c\u982d\u9838\u764c\u767c\u751f\u7387\u70ba\u53f0\u7063\u7b2c\u56db\u540d\uff0c\u4e14\u70ba\u53f0\u7063\u7b2c\u4e94\u5927\u764c\u75c7 […]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[19],"tags":[60],"class_list":["post-656","post","type-post","status-publish","format-standard","hentry","category-19","tag-60"],"_links":{"self":[{"href":"https:\/\/web.csh.org.tw\/web\/cshmagazine\/index.php?rest_route=\/wp\/v2\/posts\/656"}],"collection":[{"href":"https:\/\/web.csh.org.tw\/web\/cshmagazine\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/web.csh.org.tw\/web\/cshmagazine\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/web.csh.org.tw\/web\/cshmagazine\/index.php?rest_route=\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/web.csh.org.tw\/web\/cshmagazine\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=656"}],"version-history":[{"count":2,"href":"https:\/\/web.csh.org.tw\/web\/cshmagazine\/index.php?rest_route=\/wp\/v2\/posts\/656\/revisions"}],"predecessor-version":[{"id":659,"href":"https:\/\/web.csh.org.tw\/web\/cshmagazine\/index.php?rest_route=\/wp\/v2\/posts\/656\/revisions\/659"}],"wp:attachment":[{"href":"https:\/\/web.csh.org.tw\/web\/cshmagazine\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=656"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/web.csh.org.tw\/web\/cshmagazine\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=656"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/web.csh.org.tw\/web\/cshmagazine\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=656"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}